semaglutide ckd approval Novo's Ozempic wins FDA nod to curb kidney disease risks The FDA has approved #semaglutide
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 73.Pieber TR, Bode B, Mertens A, Cho YM, Christiansen E, Hertz CL, Wallenstein SOR, Buse JB, PIONEER 7 investigators

GLP-1s reduce energy intake by 16-9% compared with placebo, related to changes in cravings, hunger, and fullness

Health Canada Timeline Health Canada often reviews in parallel with the FDA and can approve a drug 6 to 12 months after US approval
Your clinician will review efficacy, side effects, dosing schedules, and cost to choose the best option for you

Then discuss with your doctor about higher dose, alternative GLP-1 or adjunct therapy